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KNOWLEDGE SUMMARY 
 
 
 
 
 
 
Clinical Scenario  
During veterinary clinics, you find that clients are asking you about a herbal diffuser, Pet Remedy, that they have 
seen marketed in pet shops and online, as a method to reduce stress levels in dogs and make them calmer. They 
notice that the product has been endorsed by a human psychiatrist as efficacious in dogs but wonder what you, 
the veterinary professional, think about this product. You pause, think, and realise that you do not know 
anything at all about this product so decide to undertake a review of the published scientific literature in order 
to be able to provide the client with evidence-based advice. You also note that the manufacturer reports having 
studies to support the product’s use so decide to contact them direct for further details. 
 
 
The evidence  
Three studies were included in this Knowledge Summary, of which one found no efficacy of Pet Remedy in a 
stressed dog sample (Taylor and Madden, 2016), one found that it was efficacious at improving 
behaviour/reducing excitability in a sample of dogs that might be stressed (Unex Designs Ltd., 2014), and one 
found a significant positive effect of Valerian alone (not as part of the Pet Remedy product) that might reflect 
lowered stress levels (Binks et al., 2018). Two of the studies (Taylor and Madden, 2016; Unex Designs Ltd. 2014) 
used the product Pet Remedy in their clinical trial, and were supported financially by the producers of Pet 
Remedy (Unex Designs Ltd., Torquay, Devon, UK). The Binks et al. (2018) was tentatively included due to Valerian 
being a key component of Pet Remedy, shelter dogs being a population of dogs identified as experiencing stress 
(Hermiston et al., 2018) and the mode of administration (environmental application, but not diffuser). However, 
PICO question 
In stressed dogs, does using a Pet Remedy diffuser, compared to not using one, result in lowered stress levels? 
Clinical bottom line 
Three studies were reviewed, two that investigated Pet Remedy and one that investigated Valerian (an active 
ingredient in Pet Remedy) on aspects of canine behaviour associated with stress. The highest quality study was 
a randomised controlled trial that found that Pet Remedy had no significant effect on particularly stress-
susceptible dogs exposed to an acute stressor. The weakest quality study was a randomised controlled trial 
that found a significant positive effect, but had high levels of industry involvement, weak and incomplete 
scientific reporting and methodology, and was not peer-reviewed prior to publication. Thus, the findings are 
unreliable. The final study, which was a quasi-experimental, fixed treatment order, controlled trial, found a 
positive effect of environmentally applied Valerian (on its own) on behaviour in shelter dogs. However, 
experimental design limited interpretation of the findings in relation to canine stress reduction, and external 
validity in relation to applicability to Pet Remedy use is weak. 
Where used as an adjunct, Pet Remedy is unlikely to do any direct animal welfare harm and may have a 
positive effect, based on studies that have unreliable findings and/or low external validity. However, unless 
further high quality research demonstrates a positive effect of Pet Remedy, veterinary professionals should be 
cautious about recommending it as an alternative to options with a stronger evidentiary basis, or as a delay to 
seeking more extensive professional support where needed. There is a need for further research to examine 
the efficacy of Pet Remedy on behavioural and physiological indices of canine stress reduction across a range 
of common stressful scenarios to further support veterinary professional decision making. 
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when interpreting the efficacy of Pet Remedy based on these findings this should be borne in mind. One study 
(Taylor and Madden, 2016) purposively selected dogs subjectively assessed as stressed by the owners for 
inclusion in the study, and one study provides insufficient detail to assess this aspect (Unex Designs Ltd., 2014). 
All of the studies focused on behavioural parameters, and there are currently no studies that examined the 
effects of Pet Remedy (or its constituent parts applied environmentally/topically) on physiological indicators of 
stress. 
 
Two studies (Taylor and Madden, 2016; Unex Designs Ltd., 2014) used a randomised controlled trial design and 
the other (Binks et al., 2018) used a fixed treatment order, quasi-experimental, controlled trial design. Two of 
the studies were published in peer-reviewed scientific journals (Binks et al., 2018; Taylor and Madden, 2016). 
The other (Unex Designs Ltd. 2014) was obtained by public request from the producer of Pet Remedy and has 
not been through the peer review process but is supplied direct to veterinary professionals asking for evidence 
as to the efficacy of the product. This study contained insufficient experimental detail to fully appraise key 
aspects of the study design (including the method of delivering Pet Remedy or what the placebo was, essential 
sample population details or behavioural protocols used), and the findings for most outcome measures were 
not reported. 
 
 
Summary of the evidence 
 
1. Taylor and Madden (2016) 
Population: Adult (1–11-years-old, mean: 4.6 years) pet dogs of any breed, sex 
or neuter status that had previously exhibited signs of stress, plus 
anxiety in new situations (as reported by the owner in a pre-
selection interview).  
 
Dogs that were aggressive to strangers or too anxious to handle 
safely were excluded from the trial. 
Sample size: 28 dogs 
Intervention details: This study was a cross over design, with each dog used as its own 
control. Dogs were randomly allocated to their order of treatment 
(how is not specified). 
 
The two interventions were: 
1. Placebo control  
2. Pet Remedy  
 
The Pet Remedy product was a commercially available preparation 
that includes a 5.37% essential oil blend (Valerian, Vetiver, Basil and 
Sage) in a volatile base, delivered via a diffuser. 
 
The placebo used the same diffuser type containing only the volatile 
base. 
 
Dogs were randomly allocated to the order in which they 
experienced the two treatments to control for order effects (1. 
Placebo first, followed by Pet Remedy: n = 15; 2. Pet Remedy first, 
followed by Placebo: n = 13), with approximately 7 days between 
the dog receiving each treatment. 
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A power calculation was used to determine appropriate sample size. 
The statistical analysis was a multivariate regression analysis, with 
treatment, individual dog and order of treatment as fixed effects. 
 
Experimental set up: 
The test pen was a room novel to the dog (at the start of the study), 
that measured 3 x 3 m, and contained a bed, bowl, and diffuser. A 
camera allowed remote recording of the dog. The room had 
washable walls, floor and internal furniture and a built-in fan, with 
all being cleaned between subjects/tests and a two day period left 
between testing any two dogs to allow any diffuser residual smells 
to dissipate. 
 
Testing procedure: 
The diffuser was turned on 30 minutes before the test subject (dog) 
entered. The dog was placed into the room alone for 30 minutes 
(the details of this process are missing). A camera filmed the dog’s 
behavior over the thirty minutes. The dog was then removed. Thus, 
the length of each treatment was 30 minutes, with approximately 7 
days between treatments. 
 
Data analysis: 
The video footage was renamed by a naïve assistant so that the 
researcher was blind to the treatment the dog was receiving at the 
time. The researcher recorded the behaviours according to a pre-
prepared ethogram of behaviours (see outcome measures). 
 
The University of Exeter’s ethical review group approved the study. 
Study design: Randomised controlled trial 
Outcome studied: 1. Duration of time that the dogs spent performing each of the 
following behaviours: 
- Autogrooming 
- Digging 
- Drinking 
- Lying down 
- Nosing 
- Locomotion 
- Hind legs (standing on hind legs only) 
- Sitting 
- Standing 
- Circling 
- Chewing 
- Stretching 
- Exit rear(“Time spent standing on hind legs with front 
legs resting or digging against exit” Taylor and Madden, 
2016) 
- Wall bounce 
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2. Frequency with which each of the following behaviours was 
performed: 
- Barking 
- Howling 
- Nose licking 
- Paw lifting 
- Sighing 
- Whining 
- Yawning 
- Urination/defecation 
- Panting 
Main findings: 
(relevant to PICO question): 
1. Duration of time behaviours performed: 
- There was no effect of treatment on the duration of 
time with which each of the 14 behaviours recorded 
were performed. Although order of treatment exposure 
was built into the statistical model, the authors do not 
report this finding in the results. 
 
2. Frequency with which behaviours performed: 
 There was no effect of treatment on the frequency 
with which the nine behaviours recorded were 
performed. Dogs exposed to Pet Remedy tended to 
sigh less (P = 0.052). 
Limitations:  The study was industry funded (by Unex Designs Ltd.) 
 The inclusion criteria were based on subjective assessment 
by the owners, with no attempt to standardise level of 
‘stress’ between dogs (or to control for it statistically).  
 The treatment groups were not evenly allocated to control 
for order effects. 
 The authors do not report whether the dogs were currently 
taking any medications or other supplements that might 
have an anti-stress/anxiolytic effect. 
 Insufficient detail is provided with regards to how the dog 
was handled in the lead up to entering the room e.g. was 
the owner present immediately prior to testing 
commencing, was this standardised between dogs, etc.? 
 Some of the behaviours measured are not clear measures of 
stress. 
 
 
 
 
2. Binks et al (2018) 
Population: Healthy adult (18 months–9-years-old, mean age: 4 years and 4 
months) neutered dogs in a UK rescue centre. The sample 
population was mainly male (= 13), mainly medium sized (= 13) and 
mainly bull breed or bull breed crosses (n = 10). 
Sample size: 15 dogs 
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Intervention details: Each dog was used as its own control, with each dog exposed to four 
different essential oil scented cloths in order to investigate the 
effect of each odour on canine behavior within a kennel. 
The experimental and control conditions that each dog was exposed 
to included: 
1. Unscented cloth (control 1) 
2. Coconut 
3. Vanilla 
4. Valerian± 
5. Ginger 
6. No cloth (control 2) 
 
±A key herbal component of the Pet Remedy diffuser. Only the 
controls and the Valerian treatment findings will be reported in the 
main findings section. 
 
Dogs were all simultaneously exposed to the same treatment 
condition. Each dog was observed for 2 hours per day (11:00–13:00, 
with shelter visitors/potential adopters viewing dogs for the second 
hour) for 3 consecutive days per treatment. Each dog was then given 
2 days “wash out period” (no treatment provided) before being 
exposed to the next treatment condition.  
 
A standardised procedure (5 drops were applied to each cloth – 1 
per corner and one in the middle), with sterilised cloths and 
handlers wearing latex gloves to prevent scent contamination during 
handling. Cloths were scented 60 mins before being placed in the 
centre of the dog’s run, and dogs were provided with the cloth 30 
minutes before observations started. 
 
The order in which treatments were applied was randomly 
determined (how is not defined), but the same order was used for 
each dog (because they were housed relatively close to each other 
and tested on the same days). The order of exposure was in the 
same order as the treatments (1–6) listed above. 
 
Each dog’s behaviour was recorded using instantaneous scan 
sampling at 10 minutes intervals by an unblinded observer. 
 
The study was conducted in accordance with the International 
Society for Applied Ethology’s ethical guidelines for the use of 
animals in applied animal behaviour research.   
Study design: Fixed order of treatments, controlled trial 
Outcome studied: The frequency of observation points in which the dog was showing 
the following behaviours/location: 
1. Standing 
2. Sitting 
3. Moving 
4. Resting 
5. Sleeping 
 
 
Veterinary Evidence 
ISSN:2396-9776 
Vol 4, Issue 3 
DOI: https://doi.org/10.18849/ve.v4i3.219    
next review date: Jun 12th 2021 
p a g e  |  7 of 18 
 
 
 
6. Stereotyping 
7. Vocalising 
8. Located in the front half of the kennel 
Main findings: 
(relevant to PICO question): 
1. Standing 
 No significant effect of Valerian was found on the 
frequency of standing behaviour observed. 
 
2. Sitting 
 No significant effect of Valerian was found on the 
frequency of sitting behaviour observed. 
 
3. Moving 
 Dogs moved significantly less when exposed to the 
Valerian scent cloth, than when exposed to either 
the unscented cloth (z = -4.05, P < 0.001) or no cloth 
control (z = -8.34, P < 0.001). 
 The mean (± standard deviation) of observational 
points in which the dog was vocalising was:  
Valerian: 1.73 (±2.25)  
Unscented cloth: 5.80 (±4.41) 
No cloth: 12.07 (±5.74) 
 
4. Resting 
 Dogs rested significantly more when exposed to the 
Valerian scent cloth, than when exposed to the no 
cloth control (z = 4.20, P <0.001). No other pairwise 
combination was significantly different.  
 The mean (± standard deviation) of observational 
points in which the dog was resting was:  
Valerian: 9.60 (±6.15)  
Unscented cloth: 8.13 (±7.07) 
No cloth: 4.47 (±4.17) 
 
5. Sleeping 
 No significant effect of Valerian was found on the 
frequency of sleeping behaviour observed. 
 
6. Stereotyping 
 Stereotypical behaviours were performed at such a 
low frequency that this behavioural parameter was 
not statistically analysed. 
 
 
7. Vocalising 
 Dogs vocalised significantly less when exposed to 
the Valerian scent cloth, than when exposed to 
either the unscented cloth (z = -8.34, P < 0.001) or 
no cloth (Z = -4.66, P < 0.001) controls. 
 The mean (± standard deviation) of observational 
points in which the dog was vocalising was:  
Valerian: 2.53 (±2.70)  
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Unscented cloth: 8.67 (±6.42) 
No cloth: 13.87 (±8.84) 
  
8. Located in the front half of the kennel 
 No significant effect of Valerian was found on the 
frequency of times the dog was observed to be in 
the front half of the kennel. 
Limitations:  The observer was not blinded to treatment. 
 As the study aim was not specifically to look at the effect of 
Valerian on stress, the pre-existing stress levels of the dogs 
was not assessed. 
 The dogs considered (by rescue centre employees) to be 
most susceptible to stress were excluded. 
 All dogs received the same treatment at the same time and 
in the same order so the study is particularly sensitive to 
order effects and stochastic events that might influence dog 
behaviour during a particular treatment condition. 
 None of the behaviours measured in the ethogram are 
indicators unique to stress. 
 All of the behaviours that were significantly affected by 
Valerian could be used as measures of arousal more 
generally without reference to the emotional valence 
(positive or negative) per se.  
 Limited range of behaviours observed. 
 
 
 
 
Unex Designs Ltd. (2014) 
Population: Dogs (various breeds, ages and both sexes) with behavioural issues 
(for example anxiety, nervousness or aggression). The authors do 
not provide further demographic detail (e.g. age range). 
Sample size: 66 dogs (33 dogs per treatment group) 
Intervention details: Two treatment groups, with each dog used as its own control: 
1. Behavioural therapy + placebo 
2. Behavioural therapy + Pet Remedy 
 
On arrival dogs were given a behavioural assessment, the behaviour 
issue identified and a behavioural programme that was partly 
tailored to the individual dog was devised.  
 
Dogs were allocated to the treatment group by the order in which 
they presented at the clinic (alternated between groups). The 
handler and trainer was blinded to which treatment group dogs 
were allocated to.  
 
Each dog was assessed at four time points: 
1. January (baseline measurement) 
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2. February 
3. March 
4.  April 
With data collected at time points 2–4 being compared to the 
baseline measurement for each dog. 
 
Each dog, and handler, came to the Animal Behaviour Centre on 
several occasions each month to work with the trainer on a 
combination of set exercises, plus exercises specific to the individual 
dog. The owner also undertook training at home. It is not stated 
whether the number of centre visits, trainer(s) or at home training 
sessions were standardised between dogs. The set exercises are not 
fully defined, with only examples (hand feeding, door manners) of 
the type of exercises provided. 
 
It is not clear when or how the dog was exposed to the intervention 
(Placebo or Pet Remedy, dependent upon the group the dog was in), 
but it appears to have been within the training centre environment. 
 
It is not clear exactly when and how the dogs were scored 
(excitement/behavior) at each of the four time points. 
Study design: Randomised controlled trial 
Outcome studied: Subjective measures were used: 
1. Behaviour score – ordinal scale ranging from 0 
(poor/unacceptable) to 5 (normal/good behaviour), with 
half-points allowed. 
2. Excitement level – 0 (not excited) to 5 (very excited), with 
half-points allowed. 
For both measures, the data was handled as follows: 
 The difference between the score/level awarded in January 
(baseline) and each subsequent experimental month 
(individually) was calculated for each dog. 
 This ‘differences’ data for each experimental month was 
compared statistically inter-treatment groups. 
 
Other outcome measures: 
1. Licking of paws – yes/no 
2. Licking of bedding – yes/no 
3. Suckling – yes/no 
4. Paw over lead – yes/no 
5. Jumping up – yes/no 
6. Turning in circles – yes/no 
Main findings: 
(relevant to PICO question): 
Subjective measures: 
1. Behaviour score 
 The median (range) behaviour score for the placebo group 
was:  
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January: 1 (1–1) 
February: 2 (1–3) 
March: 3 (2–4) 
April: 3.5 (2.5–4.5) 
 The median (range) behaviour score for the Pet Remedy 
group was: 
January: 1 ( 1–1) 
February: 2.5 ( 1–3) 
March: 3 (1.5–4) 
April: 4 (2–5) 
 A statistically significant difference was observed between 
the placebo and Pet Remedy treatment groups in February 
(P = 0.0011), March (P = 0.0070) and April (P = 0.0047) 
 However, the 95% confidence interval associated with the 
change (compared to baseline) in behaviour level seen by 
each month was 0.0– -1.0 
 
2. Excitement level 
 The median (range) score for excitement for the placebo 
group was: 
January: 4 (4–4) 
February: 3 (1.5–4) 
March: 2 (1–3)  
April: 1.5 (0.5–3)  
 The median (range) score for excitement for the Pet Remedy 
group was: 
January: 4 (4–4) 
February: 2.5 (1.5–4) 
March: 2 (1–3) 
April: 1 (0–2.5)  
 A statistically significant difference was observed between 
the placebo and Pet Remedy treatment groups in February 
(P = 0.0036), March (P 0.0069) and April (P = 0.0009) 
 However, the 95% confidence interval associated with the 
change (compared to baseline) in behaviour level seen by 
each month was 0.0– -1.0 for the difference between 
baseline and February and 0.0–0.5 for the January to March, 
and January to April time points 
 
Other measures: 
1. Licking of paws 
 Findings not reported 
2. Licking of bedding 
 Findings not reported 
3. Suckling 
 Findings not reported 
4. Paw over lead 
 Findings not reported 
5. Turning in circles 
 Findings not reported 
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Limitations:  The study was funded by the producers of Pet Remedy. The 
level of other involvement is not stated but a commercial 
statistical services company was hired by them to help 
design and analyse the study, and the disseminated report is 
produced by the statisticians hired to do so. There is no 
statement to outline the limit of their involvement in this 
study. 
 The study has not been published in the scientific press and 
so was not subject to the accepted peer review process prior 
to its findings being reported publicly. 
 There is insufficient information provided to allow this study 
to be replicated by independent researchers. 
 There is insufficient information provided to allow the 
presence of, for example, confounding variables that might 
also explain the findings to be identified. 
 The authors’ do not state the aim of the study until midway 
through the methods section. The aim is very broad; to see if 
behavioural therapy plus Pet Remedy is more effective than 
just behavioural therapy alone, but combined with the 
inclusion criteria this is very broad. 
 The inclusion criteria are inadequately defined. There is no 
measure of severity of the behaviour problem, and, from the 
limited information provided, the behavioural problems 
were diverse. It is not clear from the description of the 
sample how many of these dogs were stressed (i.e. if the 
paper addresses the PICO). 
 A negative control that did not include behavioural therapy 
would have been useful here. 
 It is reported that sample size calculations were performed 
but not what the test was, what parameters were used to 
estimate minimum necessary sample size (e.g. power, effect 
size), or what that minimum size was. Thus, it is not known 
whether the eventual sample size was based upon this 
calculation. 
 Dogs were assessed at the start of the study to establish 
what the problem was and what behavioural therapy was 
needed. A protocol was then devised that was partially 
tailored to the individual dog in terms of the training 
administered. However, insufficient detail is available here 
in terms of the nature of the exercises/therapy or the 
frequency with which they were carried out.  
 It is not clear whether these dogs were involved in 1-2-1 
training or in group training sessions. If the later, this may 
have reduced independence of each observation and raised 
questions about the true sampling unit. 
 There is no information available on what the placebo was 
or how it was administered. 
 There is no information on what Pet Remedy is or what 
formulation or method of dissemination was used (e.g. 
diffuser, or spray/topical or environmental application?). 
 There is insufficient information on where the dogs were 
exposed to Pet Remedy/Placebo (training venue, home, 
 
 
Veterinary Evidence 
ISSN:2396-9776 
Vol 4, Issue 3 
DOI: https://doi.org/10.18849/ve.v4i3.219    
next review date: Jun 12th 2021 
p a g e  |  12 of 18 
 
 
 
both, etc.?) and whether this was standardised between 
dogs. 
 Anecdotally, Pet Remedy has a distinctive aroma so it seems 
reasonable to assume that, despite blinding, the presence of 
the product would be detectable by the dog, owner, and 
behaviourist/trainer exposed to the product. 
 The manufacturers claim that the product works on all 
animals. If this product had any effect on the individuals 
rating the dogs’ behaviour, was the perception affected by 
exposure to Pet Remedy? It is impossible to disentangle any 
effects of Pet Remedy on the rater with any effects on the 
dog’s behaviour as they are confounded. 
 The authors report that data was collected for each dog at 
four time points (January/February/March/April) at monthly 
intervals, but it is not clear how these time points were 
separated temporally. Was there an equal number of days 
between time points, and was this the same for each dog?  
 The primary outcome measures were both subjective 
measures. No attempt to reduce subjectivity (e.g. through 
detailed descriptors for each category) appears to have been 
undertaken. 
 It is unclear who undertook the measurement of the primary 
outcome measures, or when in the session this occurred. 
 There does not appear to be any attempt to assess inter-
observer reliability (e.g. would two people award the same 
score to the same dog measured at the same time point), or 
intra-observer reliability (the latter would be more 
problematic to achieve though given the design). 
 The primary outcome measures are very limited in their 
scope (e.g. what behaviours contribute to a global 
assessment of the dog’s excitement or behavioural levels?). 
 The study reports also collecting proxy measures for stress 
but does not then report any analyses for these measures. It 
refers to these as objective, but in the same sentence refers 
to them as incidences of “excessive behavior”. “Excessive” 
suggests a subjective assessment, not an objective one. 
 No detail is available as to how the proxy measures for 
stress were measured. For example, did the researchers use 
continuous sampling, instantaneous sampling or fixed time 
intervals (if the latter, at what time points), all occurrences 
or one–zero measures, etc. When were these measured? 
During centre behaviour sessions, at home, etc.? 
 Neither of the primary outcome measures specifically 
measure stress, and the authors do not justify by reference 
to the wider literature the choice of outcome measures 
selected. 
 It is difficult to comment fully on the suitability of the 
secondary measures either without more information on 
how/when these measurements were taken and how they 
addressed the study aim. However, the authors mention 
stress so if the aim was to measure stress it is not clear why 
the authors did not pick more universal or subtle measures 
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of potential stress like yawning.  
 It is not stated whether this study was reviewed by an ethics 
committee or whether informed consent was obtained from 
the clients. 
 The researchers do not report whether the data was 
normally distributed or not, and present both parametric 
and non-parametric measures for the raw data. The inter-
quartile range is not reported. The median is reported in this 
Knowledge Summary as this reflects the type of analytical 
statistics (non-parametric) that the authors undertook.  
 The lower boundary for the 95% confidence interval for all 
differences data parameters reported was 0.0, which could 
mean that the true median value for the difference between 
the two groups was zero (or no difference). Nb. It is 
assumed median due to the values reported and the 
distribution around the median difference value, but the 
authors do not state this, and mean and standard deviation 
values are also reported. The researchers do not 
acknowledge this possibility in the summary of findings. 
 
 
Appraisal, application and reflection 
 
Three studies were included in this Knowledge Summary. Of the two directly using Pet Remedy, one found no 
efficacy of Pet Remedy in a stressed dog sample (Taylor and Madden, 2016) and the other found that it was 
efficacious at improving behaviour/reducing excitability in a sample of dogs that might be stressed (Unex 
Designs Ltd. 2014). The final study found a significant positive effect of Valerian alone (not as part of the Pet 
Remedy product) that might reflect lowered stress levels (Binks et al., 2018). All three studies focused on 
behavioural parameters as proxy measures of stress, and there are currently no studies that examine the 
effects of Pet Remedy (or its constituent parts applied environmentally/topically) on physiological signs of 
stress. This is a significant limitation to the current body of evidence examining the efficacy of Pet Remedy on 
canine stress. 
The only study (Unex Designs Ltd., 2014) to show that Pet Remedy, as a product, had a positive effect on indices 
of canine behaviour was an industry designed, reported, and funded randomised controlled trial, and obtained 
direct from the producer of Pet Remedy, rather than via a peer reviewed journal. Industry sponsored 
pharmaceutical studies have been shown to be more likely to identify a significant positive effect when using 
their product in the human healthcare industry (e.g. Chartres et al., 2016; Lexchin et al., 2003). Studies 
associated with a financial tie are 3.23–4.05 times more likely to report a positive significant effect of the 
sponsor’s product (Ahn et al., 2017; Lexchin et al., 2003). Whilst understudied in the veterinary profession, a 
similar effect has been observed with commercially funded studies significantly more associated with a positive 
outcome (Wareham et al., 2017). The peer review process, whilst recognised as imperfect (e.g. Smith, 2006), 
is an integral part of the scientific process, that is designed to improve the quality of scientific reporting. 
However, the producer claimed to have undertaken a scientific study, and historically had used this scientific 
output in literature supplied to veterinary professionals to support the use of Pet Remedy. Thus it was deemed 
appropriate to evaluate any relevant study for quality too as it was a resource that might be used to 
scientifically inform clinical decision making. Unfortunately, the level of detail provided in the submission does 
not permit an adequate evaluation of the quality of the scientific study, which limits evaluation of both internal 
and external validity. However, the reporting of the study was very low quality, with numerous omissions of 
information (see limitations section for the evaluation of this individual study) integral to understanding the 
scientific methodology utilised. Finally, if Pet Remedy is potentially efficacious for all mammals (Pet Remedy, 
2018) then the assessor (as a fellow mammalian species) may also show altered behaviour when exposed to 
the product. They are also exposed to Pet Remedy at the same time as the dog and while making the 
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assessment of the dog’s behaviour. Therefore, there is a confounding variable here that means that, if there is 
an effect, it is impossible to disentangle it from an effect on the dog, the human (e.g. that influences their 
interpretation of the dog’s behaviour) or various hypothetical interactions. Thus, it concluded that the study 
provided by Unex Designs Ltd. is unreliable and should not be used to inform the decision making of veterinary 
professionals. It underpins the importance of not simply relying on where the study type would sit on the 
pyramid of evidence when assessing experimental evidence. 
By contrast, the study by Taylor and Madden (2016), whilst funded by Unex Designs Ltd. (2016) was otherwise 
independent of the funder. This study was also a randomised controlled trial that utilised a cross over design 
to assess the effects of an acute stressor (a novel environment combined with, it is assumed, solitary 
confinement) for a 30 minute duration. This study was the strongest in terms of addressing the PICO. Both the 
population studied and some of the outcomes measures to evaluate the effect of Pet Remedy most closely 
matched the requirement for dogs to be stressed and for the reduction in stress to be measured using 
parameters recognisable as at least partially associated with a stressed (or anxious/fearful) dog. Furthermore, 
the experimental methodology (video recording for later remote analysis by a blinded observer) removed an 
important source of bias and confound present in the Unex Designs Ltd. (2014) study. This study found no 
significant effects of Pet Remedy on 23 indices of canine behaviour. It is suggested that this study is a more 
reliable source of evidence for veterinary professionals to consult when considering using Pet Remedy in 
situations that may cause a susceptible dog to experience an increase in stress levels. 
Finally, the Binks et al., 2018 quasi-experimental, fixed treatment order, controlled study was tentatively 
included, as Valerian is one of the primary herbs included in the Pet Remedy diffuser/spray and both products 
can be applied environmentally. Valerian was applied environmentally (on a scent cloth) in the Binks et al., 
(2018) study. Whilst the inclusion criteria was not specifically stress-associated (e.g. history of vet or owner 
identified susceptibility to stress, anxiety or fear) the rescue kennel environment is considered to be a 
significant stressor for rescue dogs (e.g. Hermiston et al., 2018) so it is reasonable to assume that dogs would 
be experiencing some stress. It should be noted though that the study excluded dogs considered most likely to 
be stressed in kennels. A key weakness here in relation to the PICO though, is that a baseline measurement to 
identify dogs that showed signs of stress was not undertaken. Whilst the control conditions preceded and 
concluded the order in which treatments were applied, these controls differed in terms of what they controlled 
for. The first control condition controlled for scent only (by providing a cloth that was also a novel inclusion 
within the dog’s environment) so not a true baseline measurement. Furthermore, the outcome measures (a 
limited ethogram) used to evaluate the effects of Valerian on canine behaviour do not allow the reader to 
disentangle positive (e.g. excitement) and negative (e.g. stress) arousal states. However, it is worth noting that 
they did find a significant effect of Valerian on dog behaviour, with dogs showing reduced vocalisation and 
movement, and increased resting behaviour on days (3 consecutive days) when Valerian impregnated cloths 
were placed in the run. These findings might support the findings of the Unex Design Ltd. (2014) study and 
provide an alternative explanation (other than stress reduction) for any effect of Valerian based products on 
canine behaviour. However, using these findings to justify a specific product’s use is more problematic given 
differences in the method of delivery, the concentration of the product, and the presence of synergistic, 
additive or negative/antagonistic effects that may be present in a product that combines multiple ingredients 
that may have a clinical effect on canine behaviour. Thus, while the findings of Binks et al., (2018) are interesting 
in relation to the potential use of Valerian to modify canine behavior, the external validity of this is not strong 
enough to use as evidence of efficacy of Pet Remedy, and more research is needed that uses Pet Remedy the 
product.  
In conclusion, there is currently insufficient evidence to show that Pet Remedy does work as an environmental 
tool to reduce stress in dogs. The poorest quality evidence using a non-peer reviewed randomised controlled 
trial found a significant positive effect, but the findings are unreliable due to the quality of experimental design 
and inadequate reporting of the methodology and results. The strongest quality evidence, using a single 
blinded, randomised, controlled trial, found no effect of Pet Remedy on indices of canine behaviour. There is 
some evidence that Valerian (an active ingredient in Pet Remedy) may affect canine behaviour in a potentially 
stressful environment in the medium term, though the affective state sitting behind the behavioural change is 
unclear.  
Given the anecdotal popularity of this product as an over-the-counter product to sell to pet owners, there is a 
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need for further research to investigate the effect of Pet Remedy on both behavioural and physiological indices 
of canine stress levels across a range of common scenarios of relevance to the pet owner and veterinary 
professional. However, there is also no evidence that Pet Remedy will negatively affect canine stress levels 
either, with these findings consistent across all studies reviewed so, when used as an adjunct, it is unlikely to 
do any direct animal welfare harm. However, until further research demonstrates a positive effect of Pet 
Remedy, veterinary professionals should be cautious about recommending Pet Remedy as an alternative to 
options with a stronger evidentiary basis, or as a delay to seeking more extensive professional support where 
needed. 
 
 
Methodology Section 
 
 
Search Strategy 
Databases searched and dates 
covered: 
PubMed on NCBI platform 1970 – 12/06/2019; Web of Science: 1970 
– 12/06/2019; CAB Abstracts on OVID platform: 1973 – week 22 
2019 
 
Grey literature search:  
Request sent to the Pet Remedy supplier for copies of any studies 
showing that Pet Remedy was efficacious (no species defined). 
Original request (reply): 31/05/2018 (31/05/2018), request for 
updates: 25/10/2018, no reply received by the time of submission of 
this Knowledge Summary for review (01/11/2018), or by the time 
the revised draft was submitted (21/02/2019), or by the time the 
final draft proof was approved by the author for publication 
(12/06/2019). 
Search terms: PubMed: 
(Dog or dogs or canine or canines or canis or canid or pup or puppy 
or puppies or bitch or bitches) AND (“Pet Remedy” or Valerian or 
vetiver or “sweet basil” or “clary sage” or herb or herbs or herbal or 
“chrysopogon zizanioides” or “ocimum basilicum” or “salvia sclaria” 
or “Valeriana officinalis”) AND (Stress or stressed or stressor or 
stressful or fear or fearful or anxious or anxiety or phobia or phobic 
or distress or worried or nervous or panic or fright or scared or 
alarm or apprehensive or calm or calming or calmed) 
 
Web of Science: 
(Dog or dogs or canine or canines or canis or canid or pup or puppy 
or puppies or bitch or bitches) AND (“Pet Remedy” or Valerian or 
vetiver or “sweet basil” or “clary sage” or herb or herbs or herbal or 
“chrysopogon zizanioides” or “ocimum basilicum” or “salvia sclaria” 
or “Valeriana officinalis”) AND (Stress or stressed or stressor or 
stressful or fear or fearful or anxious or anxiety or phobia or phobic 
or distress or worried or nervous or panic or fright or scared or 
alarm or apprehensive or calm or calming or calmed) 
 
CAB Abstracts: 
(Dog or dogs or canine or canines or canis or canid or pup or puppy 
or puppies or bitch or bitches) AND (Pet Remedy or Valerian or 
vetiver or sweet basil or clary sage or herb or herbs or herbal or 
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chrysopogon zizanioides or ocimum basilicum or salvia sclaria or 
Valeriana officinalis) AND (Stress or stressed or stressor or stressful 
or fear or fearful or anxious or anxiety or phobia or phobic or 
distress or worried or nervous or panic or fright or scared or alarm 
or apprehensive or calm or calming or calmed) 
Dates searches performed: PubMed: 12/06/2019; Web of Science: 12/06/2019; CAB Abstracts: 
12/06/2019 
 
 
Exclusion / Inclusion Criteria 
Exclusion: Pre-defined exclusion criteria: non-English language, popular press 
articles, conference abstracts 
Inclusion: Any comparative (control group utilised) study in which the effect of 
Pet Remedy (or its constituent parts, applied environmentally or 
topically) on stress (or similar) in dogs was studied. 
 
 
Search Outcome 
Database 
Number 
of 
results 
Excluded – 
did not 
answer 
PICO 
question 
Excluded – not 
English 
language 
Excluded – 
conference 
abstract only 
Excluded – 
duplicates 
Total 
relevant 
papers 
Pubmed 41 40 0 0 0 1 
Web of 
Science 
46 44 0 0 1 1 
CAB 
Abstracts 
88 86 0 0 0 1 
Pet Remedy 
– direct 
request for 
information 
6 5 0 0 0 1 
Total relevant papers when duplicates removed 3 
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